Free Trial

Universal Health Services (UHS) Financials

Universal Health Services logo
$192.46 +6.25 (+3.36%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$192.49 +0.03 (+0.02%)
As of 05/27/2025 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Universal Health Services

Annual Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
1,142 718 676 992 944 815 780 752 702 681
Consolidated Net Income / (Loss)
1,163 719 657 988 953 828 798 771 747 751
Net Income / (Loss) Continuing Operations
1,163 719 657 988 953 828 798 771 747 751
Total Pre-Tax Income
1,498 940 866 1,293 1,252 1,066 1,035 1,135 1,156 1,146
Total Operating Income
1,682 1,175 1,004 1,363 1,358 1,216 1,175 1,280 1,281 1,259
Total Gross Profit
8,309 7,174 6,637 6,478 5,946 5,789 5,518 5,429 5,181 4,831
Total Revenue
15,828 14,282 13,399 12,642 11,559 11,378 10,772 10,410 9,766 9,043
Operating Revenue
15,828 14,282 13,399 12,642 11,559 11,378 10,772 10,410 9,766 9,043
Total Cost of Revenue
7,519 7,107 6,762 6,164 5,613 5,589 5,255 4,981 4,586 4,212
Operating Cost of Revenue
7,519 7,107 6,762 6,164 5,613 5,589 5,255 4,981 4,586 4,212
Total Operating Expenses
6,627 5,999 5,634 5,115 4,587 4,573 4,342 4,149 3,899 3,572
Selling, General & Admin Expense
5,896 5,290 4,920 4,463 3,961 3,975 3,783 3,598 3,391 3,094
Depreciation Expense
585 568 582 533 510 490 453 448 417 399
Other Operating Expenses / (Income)
146 141 132 119 116 108 106 103 92 79
Total Other Income / (Expense), net
-184 -235 -137 -70 -106 -150 -141 -145 -125 -113
Interest Expense
186 207 127 84 106 163 155 145 125 113
Other Income / (Expense), net
2.23 -28 -10 14 0.01 13 14 0.00 0.00 -
Income Tax Expense
335 221 209 306 299 239 237 364 409 395
Net Income / (Loss) Attributable to Noncontrolling Interest
21 1.51 -19 -3.96 8.84 13 18 19 45 70
Basic Earnings per Share
$17.16 $10.35 $9.23 $11.99 $11.06 $9.16 $8.35 $7.86 $7.22 $6.89
Weighted Average Basic Shares Outstanding
66.55M 69.32M 73.12M 82.52M 85.06M 88.76M 93.28M 95.65M 97.21M 98.80M
Diluted Earnings per Share
$16.82 $10.23 $9.14 $11.82 $10.99 $9.13 $8.31 $7.81 $7.14 $6.76
Weighted Average Diluted Shares Outstanding
67.90M 70.13M 73.83M 83.69M 85.59M 89.04M 93.75M 96.33M 98.38M 100.69M
Weighted Average Basic & Diluted Shares Outstanding
65.00M 67.22M 70.67M 74.81M 85.09M 86.73M 93.40M 95.70M 97.30M 98.80M
Cash Dividends to Common per Share
$0.80 $0.80 $0.80 $0.80 - $0.60 $0.40 - - -

Quarterly Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
317 332 259 289 262 216 167 171 163 175 183
Consolidated Net Income / (Loss)
322 337 266 294 266 220 168 169 162 170 177
Net Income / (Loss) Continuing Operations
322 337 266 294 266 220 168 169 162 170 177
Total Pre-Tax Income
420 438 342 382 336 281 221 225 214 222 234
Total Operating Income
455 472 384 436 389 331 285 280 279 261 276
Total Gross Profit
2,149 2,206 2,051 2,051 2,001 1,905 1,778 1,778 1,714 1,746 1,659
Total Revenue
4,100 4,114 3,963 3,908 3,844 3,704 3,563 3,548 3,468 3,447 3,336
Operating Revenue
4,100 4,114 3,963 3,908 3,844 3,704 3,563 3,548 3,468 3,447 3,336
Total Cost of Revenue
1,951 1,907 1,912 1,856 1,843 1,799 1,785 1,770 1,753 1,701 1,677
Operating Cost of Revenue
1,951 1,907 1,912 1,856 1,843 1,799 1,785 1,770 1,753 1,701 1,677
Total Operating Expenses
1,694 1,734 1,667 1,615 1,612 1,573 1,493 1,498 1,435 1,485 1,383
Selling, General & Admin Expense
1,509 1,549 1,480 1,431 1,436 1,393 1,320 1,319 1,259 1,302 1,204
Depreciation Expense
148 147 150 147 141 145 137 144 142 148 146
Other Operating Expenses / (Income)
37 38 37 36 35 35 35 35 35 35 33
Total Other Income / (Expense), net
-34 -34 -43 -54 -53 -50 -65 -55 -65 -39 -42
Interest Expense
40 40 45 49 53 54 53 49 51 44 36
Other Income / (Expense), net
5.66 5.55 2.03 -5.49 0.15 3.52 -11 -6.60 -14 4.84 -6.02
Income Tax Expense
99 101 76 88 70 62 52 55 52 52 57
Net Income / (Loss) Attributable to Noncontrolling Interest
4.95 4.65 7.20 5.18 3.99 3.24 1.02 -2.01 -0.74 -4.45 -6.00
Basic Earnings per Share
$4.87 $5.05 $3.89 $4.32 $3.90 $3.18 $2.42 $2.44 $2.31 $2.44 $2.52
Weighted Average Basic Shares Outstanding
64.97M 66.55M 66.54M 66.88M 67.20M 69.32M 68.87M 70.07M 70.54M 73.12M 72.60M
Diluted Earnings per Share
$4.80 $4.94 $3.80 $4.26 $3.82 $3.13 $2.40 $2.42 $2.28 $2.42 $2.50
Weighted Average Diluted Shares Outstanding
66.04M 67.90M 68.11M 67.92M 68.48M 70.13M 69.62M 70.84M 71.49M 73.83M 73.06M
Weighted Average Basic & Diluted Shares Outstanding
64.44M 65.00M 65.97M 66.71M 66.93M 67.22M 68.26M 69.39M 70.18M 70.67M 71.41M
Cash Dividends to Common per Share
$0.20 - $0.20 $0.20 $0.20 - $0.20 $0.20 $0.20 - $0.20

Annual Cash Flow Statements for Universal Health Services

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
10 14 22 -1,100 1,173 -94 32 45 4.67 29
Net Cash From Operating Activities
2,067 1,268 996 884 2,360 1,438 1,275 1,248 1,334 1,068
Net Cash From Continuing Operating Activities
2,067 1,268 996 884 2,360 1,438 1,275 1,248 1,334 1,068
Net Income / (Loss) Continuing Operations
1,163 719 657 988 953 828 798 771 747 751
Consolidated Net Income / (Loss)
1,163 719 657 988 953 828 798 771 747 751
Depreciation Expense
585 568 582 533 510 490 453 448 417 399
Non-Cash Adjustments To Reconcile Net Income
93 81 144 100 69 160 116 57 93 84
Changes in Operating Assets and Liabilities, net
227 -101 -386 -737 828 -39 -92 -28 77 -165
Net Cash From Investing Activities
-911 -763 -647 -914 -803 -688 -747 -685 -1,155 -913
Net Cash From Continuing Investing Activities
-911 -763 -647 -914 -803 -688 -747 -685 -1,155 -913
Purchase of Property, Plant & Equipment
-944 -743 -734 -856 -731 -634 -665 -558 -541 -379
Acquisitions
-19 -3.73 -20 -105 -52 -8.01 -110 -23 -614 -534
Purchase of Investments
13 -41 95 1.36 -24 -34 -15 -72 - -
Divestitures
39 24 12 25 8.17 9.45 14 0.11 0.00 3.39
Other Investing Activities, net
0.28 0.02 0.10 20 -3.00 -21 -36 -32 0.00 -3.30
Net Cash From Financing Activities
-1,145 -494 -318 -1,069 -385 -845 -492 -519 -171 -125
Net Cash From Continuing Financing Activities
-1,145 -494 -318 -1,069 -385 -845 -492 -519 -171 -125
Repayment of Debt
-2,653 -86 -93 -3,057 -973 -57 -844 -143 -472 -69
Repurchase of Common Equity
-671 -547 -833 -1,221 -207 -771 -397 -364 -353 -210
Payment of Dividends
-47 -60 -112 -60 -19 -69 -52 -63 -108 -102
Issuance of Debt
2,210 185 705 3,255 802 39 791 41 1,171 234
Issuance of Common Equity
15 14 14 13 12 12 10 10 9.50 8.44
Effect of Exchange Rate Changes
-0.83 3.06 -8.42 -0.50 0.74 - -2.91 - - -1.61
Cash Interest Paid
168 200 120 76 113 157 150 136 107 107
Cash Income Taxes Paid
325 258 251 363 286 261 294 371 345 381

Quarterly Cash Flow Statements for Universal Health Services

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-1.03 20 -19 17 -7.67 34 1.33 -30 8.20 35 -37
Net Cash From Operating Activities
360 658 333 679 396 452 162 363 291 297 221
Net Cash From Continuing Operating Activities
360 658 333 679 396 452 162 363 291 297 221
Net Income / (Loss) Continuing Operations
322 337 266 294 266 220 168 169 162 170 177
Consolidated Net Income / (Loss)
322 337 266 294 266 220 168 169 162 170 177
Depreciation Expense
148 147 150 147 141 145 137 144 142 148 146
Non-Cash Adjustments To Reconcile Net Income
22 22 28 27 16 22 23 16 21 80 21
Changes in Operating Assets and Liabilities, net
-132 153 -111 211 -26 65 -166 34 -34 -102 -123
Net Cash From Investing Activities
-271 -208 -266 -243 -195 -239 -176 -170 -178 -248 -73
Net Cash From Continuing Investing Activities
-271 -208 -266 -243 -195 -239 -176 -170 -178 -248 -73
Purchase of Property, Plant & Equipment
-239 -246 -248 -241 -209 -206 -200 -168 -169 -164 -162
Acquisitions
-8.31 -19 - - 0.00 - - -3.73 0.00 -1.64 -6.18
Purchase of Investments
-24 49 -42 -1.49 8.32 -33 24 -12 -19 -82 93
Divestitures
0.00 8.34 25 - 5.43 0.50 - 14 9.26 - 1.77
Other Investing Activities, net
-0.26 0.08 0.00 0.04 0.16 0.02 - - 0.00 - -
Net Cash From Financing Activities
-91 -427 -90 -420 -209 -182 18 -224 -106 -15 -179
Net Cash From Continuing Financing Activities
-91 -427 -90 -420 -209 -182 18 -224 -106 -15 -179
Repayment of Debt
-9.11 -171 -2,099 -319 -64 -31 40 -77 -17 104 33
Repurchase of Common Equity
-223 -250 -183 -96 -142 -162 -176 -125 -85 -110 -158
Payment of Dividends
-15 -9.74 -10 -8.83 -18 -13 -14 -14 -18 -14 -62
Issuance of Debt
152 - 2,198 - 12 20 165 -11 11 - 5.32
Issuance of Common Equity
3.66 4.21 3.64 3.99 3.24 3.81 3.24 3.61 2.99 3.67 3.74
Other Net Changes in Cash
1.65 - - - -0.49 - - - 1.65 - -
Cash Interest Paid
28 24 48 48 48 51 52 47 50 41 35
Cash Income Taxes Paid
5.64 88 105 129 2.67 67 57 131 2.36 69 37

Annual Balance Sheets for Universal Health Services

This table presents Universal Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
14,470 13,968 13,494 13,094 13,477 11,668 11,265 10,762 10,318 9,615
Total Current Assets
2,816 2,811 2,537 2,264 3,282 1,916 1,938 1,798 1,681 1,718
Cash & Equivalents
126 119 103 115 1,224 61 105 74 34 61
Accounts Receivable
2,178 2,238 2,018 1,747 1,729 1,561 1,510 1,501 1,440 1,302
Inventories, net
221 217 219 207 190 160 148 136 125 116
Other Current Assets
292 237 198 195 138 134 174 87 83 103
Plant, Property, & Equipment, net
6,572 6,125 5,918 5,874 5,373 5,017 4,848 4,572 4,331 3,836
Plant, Property & Equipment, gross
12,643 11,777 11,086 10,771 9,886 9,106 8,519 7,921 7,314 6,531
Accumulated Depreciation
6,071 5,653 5,167 4,896 4,513 4,090 3,716 3,349 2,983 2,695
Total Noncurrent Assets
5,081 5,032 5,038 4,956 4,822 4,736 4,474 4,392 4,305 11,766
Goodwill
3,933 3,932 3,909 3,963 3,883 3,870 3,845 3,825 3,784 3,596
Noncurrent Deferred & Refundable Income Taxes
118 86 68 46 23 16 - 3.01 1.23 0.00
Other Noncurrent Operating Assets
1,030 580 1,061 947 916 850 630 564 520 8,170
Total Liabilities & Shareholders' Equity
14,470 13,968 13,494 13,094 13,477 11,668 11,265 10,762 10,318 9,615
Total Liabilities
7,707 7,766 7,524 6,895 7,070 6,085 5,795 5,704 5,711 5,064
Total Current Liabilities
2,210 2,013 1,914 1,984 2,481 1,563 1,449 1,848 1,317 1,100
Short-Term Debt
40 127 81 48 332 88 63 546 106 63
Accounts Payable
632 614 637 659 571 447 446 442 440 366
Accrued Expenses
635 473 524 560 526 354 389 389 403 349
Current Deferred Revenue
0.00 5.38 2.40 0.01 376 0.00 - - - -
Current Deferred & Payable Income Tax Liabilities
14 2.05 4.61 11 44 2.52 2.43 18 2.15 3.99
Current Employee Benefit Liabilities
623 549 471 466 410 380 343 305 275 245
Other Taxes Payable
162 154 111 161 152 72 56 86 68 60
Other Current Liabilities
75 72 68 64 60 201 129 39 - -
Other Current Nonoperating Liabilities
30 17 16 14 9.46 19 19 24 23 13
Total Noncurrent Liabilities
5,497 5,752 5,610 4,911 4,589 4,522 4,347 3,856 4,394 3,963
Long-Term Debt
4,464 4,786 4,727 4,142 3,524 3,897 3,935 3,494 4,030 3,369
Capital Lease Obligations
376 - 396 - 601 270 - - - -
Other Noncurrent Operating Liabilities
656 967 488 769 459 330 362 306 275 279
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
13 5.19 4.70 5.12 4.57 4.33 4.29 6.70 9.32 243
Total Equity & Noncontrolling Interests
6,750 6,197 5,965 6,193 6,402 5,579 5,466 5,051 4,598 4,309
Total Preferred & Common Equity
6,666 6,149 5,921 6,090 6,317 5,503 5,389 4,990 4,533 4,250
Total Common Equity
6,666 6,149 5,921 6,090 6,317 5,503 5,389 4,990 4,533 4,250
Common Stock
0.65 0.67 0.71 0.77 0.85 0.00 0.91 0.94 0.97 0.98
Retained Earnings
6,658 6,139 5,930 6,604 6,268 5,471 5,384 4,981 4,558 4,272
Accumulated Other Comprehensive Income / (Loss)
7.20 9.29 -9.67 30 48 32 4.24 7.18 -25 -23
Noncontrolling Interest
83 48 45 103 85 75 77 62 64 60

Quarterly Balance Sheets for Universal Health Services

This table presents Universal Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
14,875 14,470 14,354 14,071 14,046 13,968 13,873 13,732 13,556 13,494 13,379
Total Current Assets
3,077 2,816 2,802 2,741 2,871 2,811 2,753 2,625 2,559 2,537 2,457
Cash & Equivalents
127 126 106 129 112 119 81 79 110 103 75
Accounts Receivable
2,412 2,178 2,214 2,157 2,299 2,238 2,234 2,103 2,032 2,018 1,902
Inventories, net
222 221 220 219 216 217 215 215 216 219 218
Other Current Assets
317 292 262 236 243 237 223 226 201 198 262
Plant, Property, & Equipment, net
6,697 6,572 6,443 6,335 6,185 6,125 6,087 6,028 5,954 5,918 5,936
Plant, Property & Equipment, gross
12,905 12,643 12,448 12,240 11,955 11,777 11,610 11,442 11,251 11,086 11,104
Accumulated Depreciation
6,209 6,071 6,006 5,905 5,770 5,653 5,523 5,414 5,297 5,167 5,167
Total Noncurrent Assets
5,101 5,081 5,109 4,996 4,990 5,032 5,033 5,080 5,043 5,038 4,986
Goodwill
3,948 3,933 3,965 3,942 3,928 3,932 3,912 3,930 3,914 3,909 3,874
Noncurrent Deferred & Refundable Income Taxes
133 118 122 108 95 86 100 110 91 68 56
Other Noncurrent Operating Assets
1,020 1,030 1,022 946 967 580 1,022 1,040 1,038 1,061 1,056
Total Liabilities & Shareholders' Equity
14,875 14,470 14,354 14,071 14,046 13,968 13,873 13,732 13,556 13,494 13,379
Total Liabilities
7,990 7,707 7,667 7,515 7,735 7,766 7,762 7,599 7,499 7,524 7,470
Total Current Liabilities
2,330 2,210 2,011 2,149 2,075 2,013 1,990 2,035 1,863 1,914 1,939
Short-Term Debt
40 40 38 128 127 127 127 111 96 81 66
Accounts Payable
2,092 632 1,896 1,926 1,830 614 1,783 1,843 1,636 637 1,795
Current Deferred & Payable Income Tax Liabilities
121 14 3.80 23 47 2.05 7.15 6.96 58 4.61 7.74
Other Current Liabilities
76 75 73 72 71 72 73 74 73 68 70
Total Noncurrent Liabilities
5,659 5,497 5,656 5,366 5,660 5,752 5,772 5,564 5,636 5,610 5,531
Long-Term Debt
4,609 4,464 4,618 4,417 4,734 4,786 4,796 4,605 4,707 4,727 4,638
Capital Lease Obligations
369 376 378 380 374 - 389 388 396 396 393
Other Noncurrent Operating Liabilities
682 656 660 570 551 967 588 571 532 488 500
Redeemable Noncontrolling Interest
13 13 5.62 5.42 4.99 5.19 4.72 4.21 4.27 4.70 4.56
Total Equity & Noncontrolling Interests
6,872 6,750 6,681 6,551 6,306 6,197 6,106 6,129 6,052 5,965 5,904
Total Preferred & Common Equity
6,786 6,666 6,606 6,485 6,257 6,149 6,065 6,087 0.00 5,921 5,855
Total Common Equity
6,786 6,666 6,606 6,485 6,257 6,149 6,065 6,087 0.00 5,921 5,855
Common Stock
6,786 0.65 6,606 6,485 6,257 0.67 6,065 6,087 - 0.71 5,855
Noncontrolling Interest
87 83 75 65 49 48 42 42 6,052 45 49

Annual Metrics And Ratios for Universal Health Services

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
10.82% 6.59% 5.99% 9.37% 1.59% 5.63% 3.48% 6.59% 7.99% 10.22%
EBITDA Growth
32.29% 8.90% -17.55% 2.21% 8.69% 4.68% -4.95% 1.77% 2.41% 15.23%
EBIT Growth
46.81% 15.50% -27.88% 1.37% 10.52% 3.33% -7.08% -0.10% 1.75% 18.44%
NOPAT Growth
45.26% 18.12% -26.88% 0.70% 9.54% 4.10% 4.19% 5.07% 0.35% 19.23%
Net Income Growth
61.70% 9.49% -33.48% 3.66% 15.13% 3.72% 3.44% 3.23% -0.47% 24.08%
EPS Growth
64.42% 11.93% -22.67% 7.55% 20.37% 9.87% 6.40% 9.38% 5.62% 24.72%
Operating Cash Flow Growth
63.05% 27.29% 12.71% -62.56% 64.08% 12.84% 2.18% -6.47% 24.86% 3.13%
Free Cash Flow Firm Growth
-20.87% 2,642.29% -109.53% -65.95% 124.67% -8.83% 3.89% -92.83% 2,652.50% 1.34%
Invested Capital Growth
4.86% -0.67% 7.77% 6.62% -1.50% 4.46% 3.65% 3.61% -44.17% 7.77%
Revenue Q/Q Growth
2.66% 1.83% 1.30% 1.51% 1.68% 1.26% 1.05% 1.63% 3.34% -0.17%
EBITDA Q/Q Growth
6.81% 3.98% -2.76% -4.83% 3.79% 7.68% -3.55% 1.82% -0.18% 0.26%
EBIT Q/Q Growth
9.30% 6.35% -5.67% -6.54% 4.78% 10.12% -5.16% 1.95% -0.59% -0.04%
NOPAT Q/Q Growth
8.69% 6.99% -4.89% -6.92% 5.43% 6.60% -5.04% 6.49% -1.23% -0.11%
Net Income Q/Q Growth
11.23% 7.35% -8.82% -6.95% 6.69% 11.36% -7.15% 6.39% -1.66% 0.11%
EPS Q/Q Growth
12.06% 7.46% -5.97% -4.68% 7.64% 13.42% -6.63% 7.28% 0.42% 0.60%
Operating Cash Flow Q/Q Growth
11.07% 13.94% -2.42% 25.58% -7.50% 0.56% -3.30% 15.94% -5.29% -6.52%
Free Cash Flow Firm Q/Q Growth
-17.02% 126.45% 80.25% 15,366.04% -34.07% -18.10% 20.49% 1,204.47% 2,542.46% -148.06%
Invested Capital Q/Q Growth
-0.58% -2.90% 1.42% 3.53% 9.38% 1.70% -0.11% 1.52% 8.55% 108.56%
Profitability Metrics
- - - - - - - - - -
Gross Margin
52.50% 50.23% 49.53% 51.24% 51.44% 50.88% 51.22% 52.15% 53.05% 53.42%
EBITDA Margin
14.33% 12.01% 11.75% 15.11% 16.17% 15.11% 15.25% 16.60% 17.39% 18.33%
Operating Margin
10.63% 8.23% 7.49% 10.78% 11.75% 10.69% 10.91% 12.30% 13.12% 13.93%
EBIT Margin
10.64% 8.03% 7.41% 10.89% 11.75% 10.80% 11.04% 12.30% 13.12% 13.93%
Profit (Net Income) Margin
7.35% 5.04% 4.90% 7.81% 8.24% 7.27% 7.41% 7.41% 7.65% 8.30%
Tax Burden Percent
77.65% 76.49% 75.84% 76.36% 76.10% 77.61% 77.13% 67.96% 64.61% 65.51%
Interest Burden Percent
88.95% 81.98% 87.22% 93.92% 92.18% 86.76% 86.97% 88.66% 90.24% 90.99%
Effective Tax Rate
22.35% 23.51% 24.16% 23.64% 23.90% 22.39% 22.87% 32.04% 35.39% 34.49%
Return on Invested Capital (ROIC)
11.58% 8.14% 7.12% 10.44% 10.63% 9.84% 9.84% 9.79% 6.79% 5.47%
ROIC Less NNEP Spread (ROIC-NNEP)
8.60% 4.52% 4.86% 8.99% 8.46% 6.98% 7.09% 7.35% 5.73% 4.78%
Return on Net Nonoperating Assets (RNNOA)
6.37% 3.68% 3.68% 5.23% 5.26% 5.13% 5.32% 6.17% 9.52% 12.02%
Return on Equity (ROE)
17.94% 11.82% 10.80% 15.67% 15.89% 14.97% 15.16% 15.96% 16.32% 17.49%
Cash Return on Invested Capital (CROIC)
6.83% 8.81% -0.36% 4.03% 12.14% 5.48% 6.26% 6.24% 63.48% -2.01%
Operating Return on Assets (OROA)
11.84% 8.35% 7.47% 10.36% 10.80% 10.72% 10.80% 12.15% 12.86% 13.55%
Return on Assets (ROA)
8.18% 5.24% 4.94% 7.43% 7.58% 7.22% 7.24% 7.32% 7.50% 8.08%
Return on Common Equity (ROCE)
17.74% 11.72% 10.66% 15.42% 15.67% 14.76% 14.94% 15.73% 15.65% 16.28%
Return on Equity Simple (ROE_SIMPLE)
17.45% 11.70% 11.10% 16.22% 15.08% 15.04% 14.81% 15.46% 16.48% 17.66%
Net Operating Profit after Tax (NOPAT)
1,306 899 761 1,041 1,034 944 906 870 828 825
NOPAT Margin
8.25% 6.29% 5.68% 8.23% 8.94% 8.29% 8.41% 8.36% 8.48% 9.12%
Net Nonoperating Expense Percent (NNEP)
2.98% 3.62% 2.26% 1.45% 2.17% 2.86% 2.75% 2.43% 1.06% 0.69%
Return On Investment Capital (ROIC_SIMPLE)
11.23% 8.09% 6.81% - - - - - - -
Cost of Revenue to Revenue
47.50% 49.77% 50.47% 48.76% 48.56% 49.12% 48.78% 47.85% 46.95% 46.58%
SG&A Expenses to Revenue
37.25% 37.04% 36.72% 35.30% 34.27% 34.94% 35.12% 34.56% 34.72% 34.21%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.87% 42.00% 42.04% 40.46% 39.69% 40.19% 40.31% 39.86% 39.93% 39.49%
Earnings before Interest and Taxes (EBIT)
1,684 1,147 993 1,377 1,358 1,229 1,189 1,280 1,281 1,259
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,269 1,715 1,575 1,910 1,869 1,719 1,643 1,728 1,698 1,658
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.78 1.69 1.68 1.69 1.81 2.23 1.95 2.09 2.20 2.67
Price to Tangible Book Value (P/TBV)
4.33 4.68 4.95 4.83 4.70 7.53 6.80 8.97 13.32 17.36
Price to Revenue (P/Rev)
0.75 0.73 0.74 0.81 0.99 1.08 0.98 1.00 1.02 1.25
Price to Earnings (P/E)
10.36 14.44 14.74 10.36 12.13 15.09 13.47 13.88 14.21 16.67
Dividend Yield
0.45% 0.53% 0.57% 0.63% 0.52% 0.43% 0.35% 0.36% 0.39% 0.35%
Earnings Yield
9.65% 6.93% 6.78% 9.66% 8.24% 6.63% 7.42% 7.20% 7.04% 6.00%
Enterprise Value to Invested Capital (EV/IC)
1.45 1.38 1.36 1.40 1.53 1.69 1.54 1.60 1.62 0.96
Enterprise Value to Revenue (EV/Rev)
1.05 1.06 1.13 1.14 1.28 1.46 1.34 1.39 1.45 1.66
Enterprise Value to EBITDA (EV/EBITDA)
7.35 8.87 9.59 7.57 7.90 9.63 8.81 8.38 8.34 9.06
Enterprise Value to EBIT (EV/EBIT)
9.91 13.26 15.22 10.50 10.87 13.48 12.17 11.31 11.05 11.93
Enterprise Value to NOPAT (EV/NOPAT)
12.78 16.92 19.85 13.89 14.29 17.55 15.97 16.64 17.10 18.20
Enterprise Value to Operating Cash Flow (EV/OCF)
8.07 12.00 15.17 16.36 6.26 11.52 11.36 11.61 10.61 14.06
Enterprise Value to Free Cash Flow (EV/FCFF)
21.66 15.62 0.00 35.95 12.51 31.52 25.12 26.10 1.83 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.72 0.79 0.87 0.68 0.70 0.76 0.73 0.80 0.90 0.75
Long-Term Debt to Equity
0.72 0.77 0.86 0.67 0.64 0.75 0.72 0.69 0.87 0.74
Financial Leverage
0.74 0.82 0.76 0.58 0.62 0.73 0.75 0.84 1.66 2.51
Leverage Ratio
2.19 2.26 2.19 2.11 2.10 2.07 2.09 2.18 2.18 2.17
Compound Leverage Factor
1.95 1.85 1.91 1.98 1.93 1.80 1.82 1.93 1.96 1.97
Debt to Total Capital
41.92% 44.20% 46.57% 40.34% 41.03% 43.25% 42.23% 44.40% 47.31% 42.98%
Short-Term Debt to Total Capital
0.34% 1.14% 0.73% 0.47% 3.06% 0.89% 0.67% 6.00% 1.21% 0.79%
Long-Term Debt to Total Capital
41.57% 43.06% 45.84% 39.87% 37.97% 42.36% 41.56% 38.41% 46.10% 42.20%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.83% 0.48% 0.44% 1.04% 0.82% 0.80% 0.85% 0.75% 0.84% 3.78%
Common Equity to Total Capital
57.25% 55.32% 52.99% 58.62% 58.15% 55.94% 56.92% 54.84% 51.85% 53.23%
Debt to EBITDA
2.15 2.86 3.30 2.19 2.39 2.47 2.43 2.34 2.44 2.07
Net Debt to EBITDA
2.10 2.79 3.24 2.13 1.73 2.44 2.37 2.29 2.42 2.03
Long-Term Debt to EBITDA
2.13 2.79 3.25 2.17 2.21 2.42 2.40 2.02 2.37 2.03
Debt to NOPAT
3.74 5.46 6.84 4.03 4.31 4.51 4.41 4.64 5.00 4.16
Net Debt to NOPAT
3.64 5.33 6.70 3.91 3.13 4.44 4.30 4.56 4.95 4.08
Long-Term Debt to NOPAT
3.71 5.32 6.73 3.98 3.99 4.42 4.34 4.02 4.87 4.08
Altman Z-Score
3.09 2.78 2.70 2.94 2.88 3.23 3.11 3.10 3.07 3.42
Noncontrolling Interest Sharing Ratio
1.15% 0.84% 1.30% 1.57% 1.41% 1.45% 1.42% 1.47% 4.10% 6.95%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.27 1.40 1.33 1.14 1.32 1.23 1.34 0.97 1.28 1.56
Quick Ratio
1.04 1.17 1.11 0.94 1.19 1.04 1.11 0.85 1.12 1.24
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
770 974 -38 402 1,181 525 576 555 7,736 -303
Operating Cash Flow to CapEx
219.02% 170.62% 135.70% 103.28% 322.73% 226.85% 191.70% 223.78% 246.36% 281.62%
Free Cash Flow to Firm to Interest Expense
4.14 4.71 -0.30 4.80 11.11 3.23 3.72 3.82 61.86 -2.67
Operating Cash Flow to Interest Expense
11.11 6.13 7.85 10.56 22.21 8.84 8.23 8.59 10.67 9.41
Operating Cash Flow Less CapEx to Interest Expense
6.04 2.54 2.07 0.34 15.33 4.94 3.94 4.75 6.34 6.07
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.11 1.04 1.01 0.95 0.92 0.99 0.98 0.99 0.98 0.97
Accounts Receivable Turnover
7.17 6.71 7.12 7.27 7.03 7.41 7.16 7.08 7.12 7.00
Inventory Turnover
34.34 32.64 31.80 31.03 32.05 36.28 36.95 38.09 37.99 37.59
Fixed Asset Turnover
2.49 2.37 2.27 2.25 2.23 2.31 2.29 2.34 2.39 2.41
Accounts Payable Turnover
12.07 11.37 10.44 10.03 11.03 12.52 11.84 11.30 11.38 11.99
Days Sales Outstanding (DSO)
50.92 54.38 51.27 50.17 51.94 49.25 51.01 51.55 51.24 52.17
Days Inventory Outstanding (DIO)
10.63 11.18 11.48 11.76 11.39 10.06 9.88 9.58 9.61 9.71
Days Payable Outstanding (DPO)
30.24 32.11 34.96 36.40 33.08 29.15 30.83 32.31 32.07 30.44
Cash Conversion Cycle (CCC)
31.30 33.46 27.79 25.53 30.25 30.17 30.06 28.83 28.77 31.44
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
11,548 11,012 11,087 10,288 9,649 9,796 9,377 9,047 8,732 15,640
Invested Capital Turnover
1.40 1.29 1.25 1.27 1.19 1.19 1.17 1.17 0.80 0.60
Increase / (Decrease) in Invested Capital
535 -75 799 639 -147 418 330 315 -6,908 1,128
Enterprise Value (EV)
16,687 15,208 15,111 14,453 14,772 16,564 14,477 14,480 14,154 15,019
Market Capitalization
11,836 10,362 9,961 10,270 11,449 12,292 10,503 10,445 9,978 11,347
Book Value per Share
$101.06 $90.08 $82.91 $75.76 $74.34 $62.84 $58.25 $52.57 $46.76 $43.16
Tangible Book Value per Share
$41.44 $32.47 $28.16 $26.46 $28.65 $18.65 $16.70 $12.27 $7.73 $6.64
Total Capital
11,644 11,114 11,174 10,388 10,864 9,837 9,469 9,098 8,743 7,983
Total Debt
4,881 4,912 5,204 4,190 4,457 4,254 3,999 4,040 4,136 3,431
Total Long-Term Debt
4,841 4,786 5,122 4,142 4,125 4,167 3,935 3,494 4,030 3,369
Net Debt
4,755 4,793 5,101 4,075 3,233 4,193 3,893 3,966 4,102 3,370
Capital Expenditures (CapEx)
944 743 734 856 731 634 665 558 541 379
Debt-free, Cash-free Net Working Capital (DFCFNWC)
520 805 602 213 -92 379 447 421 436 619
Debt-free Net Working Capital (DFNWC)
646 925 704 328 1,133 440 553 496 470 681
Net Working Capital (NWC)
606 798 623 279 801 353 489 -50 364 618
Net Nonoperating Expense (NNE)
143 180 104 53 81 116 109 99 81 74
Net Nonoperating Obligations (NNO)
4,785 4,810 5,117 4,089 3,242 4,212 3,907 3,989 4,125 11,088
Total Depreciation and Amortization (D&A)
585 568 582 533 510 490 453 448 417 399
Debt-free, Cash-free Net Working Capital to Revenue
3.29% 5.64% 4.49% 1.68% -0.79% 3.33% 4.15% 4.05% 4.47% 6.85%
Debt-free Net Working Capital to Revenue
4.08% 6.47% 5.26% 2.59% 9.80% 3.87% 5.13% 4.76% 4.81% 7.53%
Net Working Capital to Revenue
3.83% 5.59% 4.65% 2.21% 6.93% 3.10% 4.54% -0.48% 3.73% 6.83%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$17.16 $10.35 $9.23 $11.99 $11.06 $9.16 $8.35 $7.86 $7.22 $6.89
Adjusted Weighted Average Basic Shares Outstanding
66.55M 69.32M 73.12M 82.52M 85.06M 88.76M 93.28M 95.65M 97.21M 98.80M
Adjusted Diluted Earnings per Share
$16.82 $10.23 $9.14 $11.82 $10.99 $9.13 $8.31 $7.81 $7.14 $6.76
Adjusted Weighted Average Diluted Shares Outstanding
67.90M 70.13M 73.83M 83.69M 85.59M 89.04M 93.75M 96.33M 98.38M 100.69M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
65.00M 67.22M 70.67M 74.81M 85.09M 86.73M 90.78M 94.27M 96.60M 97.67M
Normalized Net Operating Profit after Tax (NOPAT)
1,306 899 761 1,041 1,034 944 906 870 828 825
Normalized NOPAT Margin
8.25% 6.29% 5.68% 8.23% 8.94% 8.29% 8.41% 8.36% 8.48% 9.12%
Pre Tax Income Margin
9.46% 6.58% 6.46% 10.23% 10.83% 9.37% 9.60% 10.90% 11.84% 12.67%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
9.05 5.55 7.83 16.46 12.78 7.55 7.68 8.82 10.25 11.10
NOPAT to Interest Expense
7.02 4.35 6.00 12.44 9.73 5.80 5.85 5.99 6.62 7.27
EBIT Less CapEx to Interest Expense
3.98 1.96 2.04 6.23 5.90 3.66 3.39 4.98 5.92 7.75
NOPAT Less CapEx to Interest Expense
1.95 0.75 0.21 2.21 2.84 1.90 1.56 2.15 2.29 3.93
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
4.03% 8.28% 17.10% 6.05% 2.01% 8.32% 6.51% 8.16% 14.52% 13.55%
Augmented Payout Ratio
61.70% 84.37% 143.88% 129.67% 23.71% 101.43% 56.32% 55.40% 61.81% 41.50%

Quarterly Metrics And Ratios for Universal Health Services

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.66% 11.08% 11.23% 10.13% 10.85% 7.44% 6.80% 6.76% 5.30% 5.24% 5.70%
EBITDA Growth
14.89% 30.12% 30.33% 38.61% 30.33% 15.83% -1.12% 10.02% 11.26% -9.74% -6.06%
EBIT Growth
18.40% 42.82% 41.01% 57.54% 46.77% 25.73% 1.49% 16.19% 19.54% -18.33% -12.41%
NOPAT Growth
13.16% 40.42% 37.57% 59.30% 45.47% 29.18% 4.39% 19.43% 20.20% -16.26% -13.48%
Net Income Growth
20.99% 53.47% 58.27% 73.85% 63.71% 28.91% -4.98% 6.63% 7.52% -27.17% -19.40%
EPS Growth
25.65% 57.83% 58.33% 76.03% 67.54% 29.34% -4.00% 10.00% 12.87% -19.33% -3.85%
Operating Cash Flow Growth
-9.17% 45.53% 105.97% 87.16% 36.34% 52.18% -26.74% 1,012.86% -34.73% -7.68% -50.10%
Free Cash Flow Firm Growth
-70.59% -151.65% 113.49% 169.49% 104.11% 155.64% 75.46% 65.40% 43.75% -49.88% 10.19%
Invested Capital Growth
2.99% 4.86% 2.41% 1.74% 2.59% -0.67% 3.75% 3.88% 6.51% 7.77% 10.00%
Revenue Q/Q Growth
-0.34% 3.80% 1.42% 1.67% 3.78% 3.95% 0.41% 2.33% 0.60% 3.33% 0.38%
EBITDA Q/Q Growth
-2.56% 16.62% -7.37% 9.15% 10.35% 16.81% -1.48% 2.62% -1.92% -0.28% 9.62%
EBIT Q/Q Growth
-3.67% 23.78% -10.38% 10.80% 16.19% 22.21% 0.13% 3.23% -0.47% -1.35% 14.64%
NOPAT Q/Q Growth
-4.24% 21.47% -11.04% 9.35% 18.84% 19.01% 3.01% -0.14% 5.53% -3.83% 17.85%
Net Income Q/Q Growth
-4.57% 26.75% -9.66% 10.72% 21.04% 30.72% -0.76% 4.27% -4.69% -3.64% 11.36%
EPS Q/Q Growth
-2.83% 30.00% -10.80% 11.52% 22.04% 30.42% -0.83% 6.14% -5.79% -3.20% 13.64%
Operating Cash Flow Q/Q Growth
-45.32% 97.74% -50.98% 71.36% -12.38% 179.86% -55.46% 24.83% -2.20% 34.73% 576.62%
Free Cash Flow Firm Q/Q Growth
103.30% -761.44% -81.75% 638.20% 160.80% 272.82% 6.04% 56.29% 21.60% 23.76% -32.46%
Invested Capital Q/Q Growth
1.99% -0.58% 2.32% -0.73% 0.50% -2.90% 1.65% 0.10% 0.54% 1.42% 1.77%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
52.41% 53.63% 51.75% 52.49% 52.06% 51.42% 49.90% 50.11% 49.44% 50.65% 49.72%
EBITDA Margin
14.85% 15.19% 13.52% 14.80% 13.79% 12.97% 11.54% 11.76% 11.73% 12.03% 12.46%
Operating Margin
11.09% 11.49% 9.69% 11.17% 10.11% 8.94% 8.01% 7.90% 8.04% 7.58% 8.27%
EBIT Margin
11.23% 11.62% 9.74% 11.03% 10.12% 9.04% 7.69% 7.71% 7.64% 7.72% 8.09%
Profit (Net Income) Margin
7.85% 8.19% 6.71% 7.53% 6.92% 5.93% 4.72% 4.77% 4.68% 4.94% 5.30%
Tax Burden Percent
76.50% 76.90% 77.86% 77.05% 79.09% 78.12% 76.19% 75.35% 75.84% 76.63% 75.49%
Interest Burden Percent
91.30% 91.69% 88.44% 88.65% 86.42% 83.99% 80.51% 82.15% 80.80% 83.51% 86.79%
Effective Tax Rate
23.50% 23.10% 22.14% 22.95% 20.91% 21.88% 23.81% 24.65% 24.16% 23.37% 24.51%
Return on Invested Capital (ROIC)
11.76% 12.39% 10.14% 11.48% 10.39% 9.03% 7.69% 7.50% 7.66% 7.29% 7.91%
ROIC Less NNEP Spread (ROIC-NNEP)
11.24% 11.85% 9.48% 10.63% 9.57% 8.24% 6.72% 6.65% 6.64% 6.64% 7.18%
Return on Net Nonoperating Assets (RNNOA)
8.53% 8.77% 7.53% 8.22% 7.90% 6.72% 5.73% 5.44% 5.29% 5.02% 5.02%
Return on Equity (ROE)
20.29% 21.16% 17.67% 19.71% 18.29% 15.75% 13.42% 12.94% 12.95% 12.31% 12.94%
Cash Return on Invested Capital (CROIC)
8.65% 6.83% 8.09% 8.23% 6.26% 8.81% 3.86% 3.79% 1.07% -0.36% -1.86%
Operating Return on Assets (OROA)
12.49% 12.94% 10.65% 11.91% 10.75% 9.40% 7.91% 7.87% 7.77% 7.78% 8.16%
Return on Assets (ROA)
8.73% 9.12% 7.33% 8.14% 7.35% 6.17% 4.85% 4.87% 4.76% 4.98% 5.35%
Return on Common Equity (ROCE)
20.05% 20.92% 17.49% 19.53% 9.25% 15.62% 13.31% 12.79% 6.32% 12.15% 6.17%
Return on Equity Simple (ROE_SIMPLE)
17.96% 0.00% 15.83% 14.61% 13.15% 0.00% 11.05% 11.15% 0.00% 0.00% 12.31%
Net Operating Profit after Tax (NOPAT)
348 363 299 336 307 259 217 211 211 200 208
NOPAT Margin
8.49% 8.83% 7.55% 8.60% 8.00% 6.99% 6.10% 5.95% 6.10% 5.81% 6.24%
Net Nonoperating Expense Percent (NNEP)
0.53% 0.55% 0.65% 0.85% 0.82% 0.79% 0.96% 0.85% 1.02% 0.65% 0.73%
Return On Investment Capital (ROIC_SIMPLE)
2.93% 3.12% - - - 2.33% - - - 1.79% -
Cost of Revenue to Revenue
47.59% 46.37% 48.25% 47.51% 47.94% 48.58% 50.10% 49.89% 50.56% 49.35% 50.28%
SG&A Expenses to Revenue
36.80% 37.65% 37.36% 36.63% 37.35% 37.60% 37.05% 37.16% 36.31% 37.76% 36.08%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.31% 42.15% 42.05% 41.33% 41.95% 42.48% 41.89% 42.21% 41.40% 43.07% 41.45%
Earnings before Interest and Taxes (EBIT)
460 478 386 431 389 335 274 274 265 266 270
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
609 625 536 578 530 480 411 417 407 415 416
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.80 1.78 2.31 1.91 1.99 1.69 1.43 1.81 0.00 1.68 1.09
Price to Tangible Book Value (P/TBV)
4.30 4.33 5.79 4.87 5.34 4.68 4.03 5.11 0.00 4.95 3.22
Price to Revenue (P/Rev)
0.76 0.75 0.99 0.82 0.85 0.73 0.62 0.80 0.66 0.74 0.48
Price to Earnings (P/E)
10.20 10.36 14.89 13.25 15.24 14.44 12.84 15.92 13.03 14.74 8.61
Dividend Yield
0.43% 0.45% 0.35% 0.43% 0.44% 0.53% 0.64% 0.51% 0.63% 0.57% 0.92%
Earnings Yield
9.80% 9.65% 6.72% 7.55% 6.56% 6.93% 7.79% 6.28% 7.68% 6.78% 11.61%
Enterprise Value to Invested Capital (EV/IC)
1.46 1.45 1.75 1.52 1.54 1.38 1.23 1.44 1.80 1.36 1.05
Enterprise Value to Revenue (EV/Rev)
1.07 1.05 1.32 1.15 1.20 1.06 1.00 1.17 1.48 1.13 0.87
Enterprise Value to EBITDA (EV/EBITDA)
7.33 7.35 9.55 8.62 9.58 8.87 8.46 9.72 12.42 9.59 7.07
Enterprise Value to EBIT (EV/EBIT)
9.80 9.91 13.17 12.07 13.86 13.26 12.94 14.97 19.36 15.22 10.87
Enterprise Value to NOPAT (EV/NOPAT)
12.78 12.78 16.88 15.39 17.70 16.92 16.62 19.35 25.19 19.85 14.31
Enterprise Value to Operating Cash Flow (EV/OCF)
8.47 8.07 10.90 10.20 12.83 12.00 12.55 13.73 23.85 15.17 11.22
Enterprise Value to Free Cash Flow (EV/FCFF)
17.13 21.66 21.85 18.61 24.91 15.62 32.47 38.79 173.61 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.73 0.72 0.75 0.75 0.83 0.79 0.87 0.83 0.86 0.87 0.86
Long-Term Debt to Equity
0.72 0.72 0.75 0.73 0.81 0.77 0.85 0.81 0.84 0.86 0.85
Financial Leverage
0.76 0.74 0.79 0.77 0.83 0.82 0.85 0.82 0.80 0.76 0.70
Leverage Ratio
2.19 2.19 2.21 2.19 2.23 2.26 2.27 2.24 2.22 2.19 2.14
Compound Leverage Factor
2.00 2.01 1.95 1.94 1.93 1.89 1.83 1.84 1.79 1.82 1.85
Debt to Total Capital
42.16% 41.92% 42.95% 42.89% 45.35% 44.20% 46.50% 45.42% 46.20% 46.57% 46.31%
Short-Term Debt to Total Capital
0.34% 0.34% 0.33% 1.11% 1.10% 1.14% 1.11% 0.99% 0.85% 0.73% 0.60%
Long-Term Debt to Total Capital
41.82% 41.57% 42.62% 41.78% 44.24% 43.06% 45.39% 44.43% 45.34% 45.84% 45.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.84% 0.83% 0.69% 0.62% 0.47% 0.48% 0.41% 0.41% 53.81% 0.44% 0.48%
Common Equity to Total Capital
57.00% 57.25% 56.36% 56.49% 54.18% 55.32% 53.10% 54.17% 0.00% 52.99% 53.20%
Debt to EBITDA
2.14 2.15 2.37 2.46 2.85 2.86 3.22 3.09 3.22 3.30 3.15
Net Debt to EBITDA
2.08 2.10 2.32 2.40 2.79 2.79 3.17 3.04 3.15 3.24 3.10
Long-Term Debt to EBITDA
2.12 2.13 2.35 2.40 2.78 2.79 3.14 3.02 3.16 3.25 3.11
Debt to NOPAT
3.73 3.74 4.19 4.40 5.26 5.46 6.32 6.14 6.53 6.84 6.37
Net Debt to NOPAT
3.63 3.64 4.10 4.28 5.15 5.33 6.22 6.05 6.39 6.70 6.28
Long-Term Debt to NOPAT
3.70 3.71 4.16 4.28 5.13 5.32 6.17 6.01 6.41 6.73 6.29
Altman Z-Score
2.16 2.82 2.42 2.21 2.17 2.59 1.81 1.99 1.84 2.52 1.61
Noncontrolling Interest Sharing Ratio
1.17% 1.15% 0.99% 0.92% 49.41% 0.84% 0.83% 1.16% 51.20% 1.30% 52.32%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.32 1.27 1.39 1.28 1.38 1.40 1.38 1.29 1.37 1.33 1.27
Quick Ratio
1.09 1.04 1.15 1.06 1.16 1.17 1.16 1.07 1.15 1.11 1.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
5.68 -172 26 143 19 333 -193 -205 -470 -599 -786
Operating Cash Flow to CapEx
150.63% 267.72% 134.30% 281.40% 190.09% 219.21% 80.83% 216.15% 172.30% 180.79% 136.56%
Free Cash Flow to Firm to Interest Expense
0.14 -4.33 0.58 2.92 0.37 6.22 -3.61 -4.20 -9.23 -13.65 -22.04
Operating Cash Flow to Interest Expense
8.99 16.58 7.46 13.89 7.50 8.44 3.03 7.43 5.71 6.77 6.19
Operating Cash Flow Less CapEx to Interest Expense
3.02 10.38 1.90 8.95 3.56 4.59 -0.72 3.99 2.40 3.03 1.66
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.11 1.11 1.09 1.08 1.06 1.04 1.03 1.02 1.02 1.01 1.01
Accounts Receivable Turnover
6.83 7.17 6.93 7.05 6.77 6.71 6.78 7.01 7.17 7.12 7.22
Inventory Turnover
34.82 34.34 34.10 33.55 33.30 32.64 32.42 32.48 32.14 31.80 31.78
Fixed Asset Turnover
2.50 2.49 2.46 2.43 2.42 2.37 2.33 2.30 2.29 2.27 2.28
Accounts Payable Turnover
3.89 12.07 4.03 3.86 4.15 11.37 3.92 3.73 3.78 10.44 3.67
Days Sales Outstanding (DSO)
53.45 50.92 52.66 51.77 53.93 54.38 53.83 52.09 50.92 51.27 50.59
Days Inventory Outstanding (DIO)
10.48 10.63 10.70 10.88 10.96 11.18 11.26 11.24 11.35 11.48 11.49
Days Payable Outstanding (DPO)
93.86 30.24 90.62 94.46 87.90 32.11 93.17 97.96 96.62 34.96 99.41
Cash Conversion Cycle (CCC)
-29.92 31.30 -27.26 -31.81 -23.01 33.46 -28.08 -34.63 -34.35 27.79 -37.34
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11,777 11,548 11,615 11,351 11,435 11,012 11,342 11,158 11,147 11,087 10,931
Invested Capital Turnover
1.39 1.40 1.34 1.33 1.30 1.29 1.26 1.26 1.26 1.25 1.27
Increase / (Decrease) in Invested Capital
342 535 273 194 288 -75 410 416 681 799 994
Enterprise Value (EV)
17,205 16,687 20,287 17,243 17,620 15,208 13,961 16,085 20,068 15,111 11,449
Market Capitalization
12,214 11,836 15,278 12,377 12,441 10,362 8,685 11,015 8,922 9,961 6,373
Book Value per Share
$104.39 $101.06 $99.02 $96.90 $93.10 $90.08 $87.40 $86.73 $0.00 $82.91 $80.24
Tangible Book Value per Share
$43.65 $41.44 $39.58 $38.00 $34.65 $32.47 $31.02 $30.74 ($55.38) $28.16 $27.15
Total Capital
11,904 11,644 11,721 11,480 11,547 11,114 11,422 11,237 11,257 11,174 11,006
Total Debt
5,018 4,881 5,034 4,924 5,236 4,912 5,311 5,104 5,200 5,204 5,097
Total Long-Term Debt
4,978 4,841 4,996 4,796 5,109 4,786 5,185 4,993 5,104 5,122 5,031
Net Debt
4,891 4,755 4,928 4,795 5,124 4,793 5,230 5,025 5,090 5,101 5,023
Capital Expenditures (CapEx)
239 246 248 241 209 206 200 168 169 164 162
Debt-free, Cash-free Net Working Capital (DFCFNWC)
661 520 723 590 811 805 809 621 682 602 509
Debt-free Net Working Capital (DFNWC)
788 646 829 719 923 925 890 701 792 704 584
Net Working Capital (NWC)
747 606 791 591 796 798 763 589 696 623 517
Net Nonoperating Expense (NNE)
26 26 33 42 42 39 49 42 49 30 31
Net Nonoperating Obligations (NNO)
4,891 4,785 4,928 4,795 5,124 4,810 5,230 5,025 5,090 5,117 5,023
Total Depreciation and Amortization (D&A)
148 147 150 147 141 145 137 144 142 148 146
Debt-free, Cash-free Net Working Capital to Revenue
4.11% 3.29% 4.69% 3.93% 5.53% 5.64% 5.77% 4.50% 5.02% 4.49% 3.85%
Debt-free Net Working Capital to Revenue
4.90% 4.08% 5.38% 4.79% 6.30% 6.47% 6.34% 5.08% 5.83% 5.26% 4.41%
Net Working Capital to Revenue
4.65% 3.83% 5.13% 3.94% 5.43% 5.59% 5.44% 4.27% 5.13% 4.65% 3.91%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.87 $5.05 $3.89 $4.32 $3.90 $3.18 $2.42 $2.44 $2.31 $2.44 $2.52
Adjusted Weighted Average Basic Shares Outstanding
64.97M 66.55M 66.54M 66.88M 67.20M 69.32M 68.87M 70.07M 70.54M 73.12M 72.60M
Adjusted Diluted Earnings per Share
$4.80 $4.94 $3.80 $4.26 $3.82 $3.13 $2.40 $2.42 $2.28 $2.42 $2.50
Adjusted Weighted Average Diluted Shares Outstanding
66.04M 67.90M 68.11M 67.92M 68.48M 70.13M 69.62M 70.84M 71.49M 73.83M 73.06M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.44M 65.00M 65.97M 66.71M 66.93M 67.22M 68.26M 69.39M 70.18M 70.67M 71.41M
Normalized Net Operating Profit after Tax (NOPAT)
348 363 299 336 307 259 217 211 211 200 208
Normalized NOPAT Margin
8.49% 8.83% 7.55% 8.60% 8.00% 6.99% 6.10% 5.95% 6.10% 5.81% 6.24%
Pre Tax Income Margin
10.26% 10.65% 8.62% 9.78% 8.74% 7.59% 6.19% 6.33% 6.17% 6.45% 7.02%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.50 12.03 8.65 8.81 7.36 6.25 5.13 5.60 5.21 6.07 7.57
NOPAT to Interest Expense
8.69 9.15 6.70 6.88 5.82 4.83 4.07 4.32 4.15 4.56 5.84
EBIT Less CapEx to Interest Expense
5.53 5.84 3.10 3.88 3.41 2.39 1.38 2.16 1.89 2.32 3.04
NOPAT Less CapEx to Interest Expense
2.72 2.96 1.15 1.94 1.87 0.98 0.33 0.88 0.84 0.82 1.31
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
3.58% 4.03% 4.77% 5.70% 7.22% 8.28% 9.02% 16.01% 16.34% 17.10% 16.03%
Augmented Payout Ratio
65.28% 61.70% 60.48% 66.43% 80.68% 84.37% 82.88% 86.34% 99.00% 143.88% 178.91%

Frequently Asked Questions About Universal Health Services' Financials

When does Universal Health Services's financial year end?

According to the most recent income statement we have on file, Universal Health Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Universal Health Services' net income changed over the last 9 years?

Universal Health Services' net income appears to be on an upward trend, with a most recent value of $1.16 billion in 2024, rising from $750.70 million in 2015. The previous period was $719.31 million in 2023. See where experts think Universal Health Services is headed by visiting Universal Health Services' forecast page.

What is Universal Health Services's operating income?
Universal Health Services's total operating income in 2024 was $1.68 billion, based on the following breakdown:
  • Total Gross Profit: $8.31 billion
  • Total Operating Expenses: $6.63 billion
How has Universal Health Services revenue changed over the last 9 years?

Over the last 9 years, Universal Health Services' total revenue changed from $9.04 billion in 2015 to $15.83 billion in 2024, a change of 75.0%.

How much debt does Universal Health Services have?

Universal Health Services' total liabilities were at $7.71 billion at the end of 2024, a 0.8% decrease from 2023, and a 52.2% increase since 2015.

How much cash does Universal Health Services have?

In the past 9 years, Universal Health Services' cash and equivalents has ranged from $33.75 million in 2016 to $1.22 billion in 2020, and is currently $125.98 million as of their latest financial filing in 2024.

How has Universal Health Services' book value per share changed over the last 9 years?

Over the last 9 years, Universal Health Services' book value per share changed from 43.16 in 2015 to 101.06 in 2024, a change of 134.2%.



This page (NYSE:UHS) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners